肝移植术后侵袭性真菌感染14例诊疗体会
摘要
肝移植术后存在真菌感染的多种高危因素，早期评估、早期预防、早期诊断和早期治疗是获得良好预后的保证。我们选取了14例行肝移植术后早期确诊或拟诊侵袭性真菌感染的患者，在调节免疫抑制剂的基础上，予以通畅的外科引流，并辅以棘白菌素类药物干预，取得较好疗效，现报道如下。
出处
《浙江医学》
CAS
2008年第9期951-953,共3页
Zhejiang Medical Journal
基金
浙江省科技厅重大攻关项目资助(No.2006C13020)
卫生部行业专项基金资助(No.20082006)
参考文献7
-
1Faouzi S, Mohamed L Risk Factors for New-Onset Diabetes Mellitus Following Liver Transplantation and Impact of Hepatitis C Infection: An Observational Multicenter Study[J]. Liver Transplant, 2007, 13: 136-144.
-
2Nieto-Rodriguez J A, Kusne S, Manez R, et al. Factors associated with the development of candidemia and candidemia- related death among liver transplant recipients[J]. Ann Surg, 1996, 223(1): 70-76
-
3Kawagishi N, Satoh K, Enomoto Y, et al. Risk factors and impact of be-ta-D glucan on invasive fungal infection for the living donor liver transplant recipients[J]. Thoku J Exp Med, 2006, 209 (3): 207-215.
-
4Rabkin J M, Oroloff S L, Corless C L, et al. Association of fungal infection and increased mortality in liver transplant recipients[J]. Am J Surg, 2000, 179:426-430.
-
5Xu X, Ling Q, Wu J, et al. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation[J]. Liver Int, 2007, 27(6):816-824.
-
6Barnes R A. Early diagnosis of fungal infection in immuno- compromised patients[J]. J Antimicrobial Chemotherapy, 2008, 61(1):13-6.
-
7Mora D J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis[J]. N Engl J Med, 2002, 347:2020-2029.
-
1姚金晓,魏旭东,张莉,房佰俊,符粤文,宋永平.米卡芬净治疗恶性血液病患者侵袭性真菌感染23例疗效分析[J].中华内科杂志,2008,47(9):758-758. 被引量：1
-
2朱丹,孟凡义,黄芬,张钰,孙启鑫,欧阳昭,徐兵,刘晓力,冯茹.卡泊芬净治疗侵袭性真菌感染27例临床研究[J].中华血液学杂志,2008,29(1):63-64. 被引量：2
-
3骆松梅,虞惠康,徐文峥,朱虹云.卡泊芬净治疗7例侵袭性真菌感染的临床分析[J].中国临床药学杂志,2010,19(1):50-51.
-
4沈杨(综述).白血病真菌感染的新药与临床治疗[J].国际输血及血液学杂志,2010(5):411-413. 被引量：1
-
5刘萍.新的全身用抗真菌药物——临床疗效和安全性[J].世界临床药物,2005,26(10):620-625.
-
6袁菲.1例米卡芬净致溶血伴急性肾功能衰竭患者的护理[J].护理实践与研究,2014,11(6):155-156. 被引量：3
